SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-055304
Filing Date
2005-11-14
Accepted
2005-11-14 14:11:51
Documents
7
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-20082_110q.htm 10-Q 795513
2 302 CERTIFICATION a05-20082_1ex31d1.htm EX-31.1 12182
3 302 CERTIFICATION a05-20082_1ex31d2.htm EX-31.2 12023
4 906 CERTIFICATION a05-20082_1ex32d1.htm EX-32.1 5688
5 906 CERTIFICATION a05-20082_1ex32d2.htm EX-32.2 5882
6 GRAPHIC g200821ba01i001.jpg GRAPHIC 5802
7 GRAPHIC g200821ba01i002.jpg GRAPHIC 697
  Complete submission text file 0001104659-05-055304.txt   842019
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 051199896
SIC: 2834 Pharmaceutical Preparations